These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 31203913)

  • 41. Recurrent Pregnancy Loss in Women with Hashimoto's Thyroiditis with Concurrent Non-Endocrine Autoimmune Disorders.
    Cellini M; Santaguida MG; Stramazzo I; Capriello S; Brusca N; Antonelli A; Fallahi P; Gargano L; Centanni M; Virili C
    Thyroid; 2020 Mar; 30(3):457-462. PubMed ID: 31910128
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of oxidative stress on the progression of Hashimoto's thyroiditis.
    Ates I; Arikan MF; Altay M; Yilmaz FM; Yilmaz N; Berker D; Guler S
    Arch Physiol Biochem; 2018 Oct; 124(4):351-356. PubMed ID: 29185364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.
    Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC
    Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis.
    Yalçin B; Tamer E; Toy GG; Oztas P; Alli N
    J Endocrinol Invest; 2005 Jun; 28(6):558-60. PubMed ID: 16117199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behçet's syndrome is not associated with vitiligo.
    Oran M; Hatemi G; Tasli L; Garip F; Kadioglu P; Mat C; Yazici H
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S107-9. PubMed ID: 19026126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis.
    Hu S; Rayman MP
    Thyroid; 2017 May; 27(5):597-610. PubMed ID: 28290237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis Markers of Hashimoto's Disease-A Mini Review.
    Jin B; Wang S; Fan Z
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):297. PubMed ID: 36336870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
    Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C
    Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2.
    Alkhateeb A; Stetler GL; Old W; Talbert J; Uhlhorn C; Taylor M; Fox A; Miller C; Dills DG; Ridgway EC; Bennett DC; Fain PR; Spritz RA
    Hum Mol Genet; 2002 Mar; 11(6):661-7. PubMed ID: 11912181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of apoptosis in thyroid autoimmunity.
    Wang SH; Baker JR
    Thyroid; 2007 Oct; 17(10):975-9. PubMed ID: 17900237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.
    Farhangi MA; Dehghan P; Tajmiri S; Abbasi MM
    BMC Complement Altern Med; 2016 Nov; 16(1):471. PubMed ID: 27852303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update on the pathogenesis of Hashimoto's thyroiditis.
    Weetman AP
    J Endocrinol Invest; 2021 May; 44(5):883-890. PubMed ID: 33332019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmunity, New Potential Biomarkers and the Thyroid Gland-The Perspective of Hashimoto's Thyroiditis and Its Treatment.
    Tywanek E; Michalak A; Świrska J; Zwolak A
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis.
    Zhang QY; Ye XP; Zhou Z; Zhu CF; Li R; Fang Y; Zhang RJ; Li L; Liu W; Wang Z; Song SY; Lu SY; Zhao SX; Lin JN; Song HD
    Nat Commun; 2022 Feb; 13(1):775. PubMed ID: 35140214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D in Hashimoto's thyroiditis and its relationship with thyroid function and inflammatory status.
    Botelho IMB; Moura Neto A; Silva CA; Tambascia MA; Alegre SM; Zantut-Wittmann DE
    Endocr J; 2018 Oct; 65(10):1029-1037. PubMed ID: 30058600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased Interleukin-23 in Hashimoto's Thyroiditis Disease Induces Autophagy Suppression and Reactive Oxygen Species Accumulation.
    Zheng T; Xu C; Mao C; Mou X; Wu F; Wang X; Bu L; Zhou Y; Luo X; Lu Q; Liu H; Yuan G; Wang S; Chen D; Xiao Y
    Front Immunol; 2018; 9():96. PubMed ID: 29434604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.
    Guclu F; Ozmen B; Kirmaz C; Kafesciler SO; Degirmenci PB; Taneli F; Hekimsoy Z
    Eur Cytokine Netw; 2009 Mar; 20(1):27-32. PubMed ID: 19318318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune aspects of vitiligo.
    Kemp EH; Waterman EA; Weetman AP
    Autoimmunity; 2001; 34(1):65-77. PubMed ID: 11681494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.